SCWorx Corp. (NASDAQ: WORX) Shares Resume Trading on Nasdaq After Compliance Reversal

• SCWorx Corp. (NASDAQ: WORX) shares are resuming trading on the Nasdaq Capital Market on October 7, 2026, following a suspension.
• The company successfully reversed a delisting decision by regaining compliance with Nasdaq's minimum bid price and publicly held shares rules.
• SCWorx reported improved financial performance in the first half of 2026, including better gross profit, net loss, and cash used in operations, alongside investments in an AI-enabled data management platform.

SCWorx Corp. (NASDAQ: WORX) is not preparing to go public. This healthcare technology stock is already listed on the Nasdaq Capital Market, and its shares resume trading on October 7, 2026, after a suspension that began April 14. The company provides essential data management tools to healthcare organizations.

The return to stock trading follows a Nasdaq Hearings Panel decision to reverse a September 17 delisting decision. As highlighted by GlobeNewswire, the panel finds that SCWorx has regained compliance with Nasdaq’s minimum bid price and publicly held shares rules, a crucial step for its market presence. Its continued listing remains subject to conditions.

SCWorx reports improved gross profit, net loss, and cash used in operations in the first half of 2026, indicating positive shifts in its financial performance. Gross profit is revenue left after direct service costs, while cash used in operations shows how much cash the business spends on its day-to-day activities. The announcement gives no specific figures for these changes, but highlights a positive trend in its financial health.

The company says it is expanding its healthcare customer relationships and investing in an AI-enabled data management platform, signaling future growth in healthcare technology solutions. In the supplied market data, SCWorx trades at $5.76, down 2.01% ($0.12), with a market value of approximately $92.20 million. The announcement does not explicitly link the trading move to its operating results, but these developments are key for investor consideration.